Samsung Biologics announced December 21 that it had purchased an old GSK human genome sciences facility in Rockville, ...
SEOUL, March 17 (Reuters) - South Korean drugmaker Samsung Biologics Co Ltd (207940.KS), opens new tab plans to invest 2 trillion won ($1.53 billion) through September 2025 to build a new factory in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback